Immunovant (4YB) Q2 2025 Earnings Report
DE:4YB Q2 2025 EPS Results
- Actual EPS
- -EUR 0.66
- Consensus EPS
- -EUR 0.54
- Beat/Miss
- Missed by -EUR 0.12
- One Year Ago EPS
- -EUR 0.40
DE:4YB Q2 2025 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 11/07/2024
- Time
- Before Open
- Conference Call
- Thursday, November 7, 2024
DE:4YB Upcoming Earnings
Immunovant's next earnings date is estimated for November 9, 2026, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4YB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 09, 2026 | 2027 (Q2) | -0.66- | -0.65 | ― | ― |
| Aug 06, 2026 | 2027 (Q1) | -0.56-0.67 | -0.63 | -5.63% (-0.04) | |
| May 20, 2026 | 2026 (Q4) | -0.53-0.65 | -0.57 | -14.06% (-0.08) | |
| Feb 06, 2026 | 2026 (Q3) | -0.64-0.54 | -0.68 | 19.74% (+0.13) | |
| Nov 10, 2025 | 2026 (Q2) | -0.64-0.65 | -0.66 | 1.35% (+0.01) | |
| Aug 11, 2025 | 2026 (Q1) | -0.61-0.63 | -0.54 | -18.33% (-0.10) | |
| May 29, 2025 | 2025 (Q4) | -0.64-0.57 | -0.46 | -23.08% (-0.11) | |
| Feb 06, 2025 | 2025 (Q3) | -0.67-0.68 | -0.26 | -162.98% (-0.42) | |
| Nov 07, 2024 | 2025 (Q2) | -0.54-0.66 | -0.4 | -64.44% (-0.26) | |
| Aug 06, 2024 | 2025 (Q1) | -0.47-0.54 | -0.51 | -5.26% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed